Prelude Therapeutics
Price & Volume
Stats
See more52W Range | $1.17-$6.83 |
Market Cap | $309.6M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $22.4M |
Revenue Growth (YoY) | 41% |
Gross Profit (12 Mos) | $22.4M |
Diluted EPS | -$0.73 |
News
See moreYahoo Finance • 17 days ago
Eli Lilly (LLY) Reported One Year Steroid Free Control In Difficult IBD
Yahoo Finance • 20 days ago
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
Yahoo Finance • 2 months ago
Biotech Breakout: What's in focus after Moderna's cancer win?
About
CEO | Dr. Krishna Vaddi D.V.M., Ph.D. |
CFO | Mr. Bryant David Lim J.D. |
Address | 175 Innovation Boulevard, Wilmington, DE, United States, 19805 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 79 |